Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,661 to 2,680 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| PLA2R1 phospholipase A2 receptor 1 | 22925 HGNC:9042 | 1 | 67 | 0 | 0 | 591 | 2,349 |
| TRIM5 tripartite motif containing 5 | 85363 HGNC:16276 | 1 | 35 | 0 | 0 | 1,840 | 2,349 |
| GCKR glucokinase regulator | 2646 HGNC:4196 | 1 | 3 | 0 | 0 | 2,296 | 2,346 |
| PPIF peptidylprolyl isomerase F | 10105 HGNC:9259 | 1 | 87 | 0 | 0 | 1,655 | 2,346 |
| PTPRF protein tyrosine phosphatase receptor type F | 5792 HGNC:9670 | 1 | 40 | 0 | 0 | 1,312 | 2,345 |
| PRSS1 serine protease 1 | 5644 HGNC:9475 | 1 | 68 | 0 | 0 | 1,188 | 2,344 |
| ETV1 ETS variant transcription factor 1 | 2115 HGNC:3490 | 1 | 69 | 0 | 0 | 1,813 | 2,342 |
| BLK BLK proto-oncogene, Src family tyrosine kinase | 640 HGNC:1057 | 1 | 31 | 5 | 225 | 1,820 | 2,339 |
| NPC2 NPC intracellular cholesterol transporter 2 | 10577 HGNC:14537 | 1 | 76 | 0 | 0 | 1,433 | 2,338 |
| DLL3 delta like canonical Notch ligand 3 | 10683 HGNC:2909 | 1 | 260 | 2 | 43 | 1,404 | 2,335 |
| ARSA arylsulfatase A | 410 HGNC:713 | 1 | 83 | 1 | 0 | 794 | 2,331 |
| ATF1 activating transcription factor 1 | 466 HGNC:783 | 1 | 31 | 0 | 0 | 1,390 | 2,331 |
| TRPM7 transient receptor potential cation channel subfamily M member 7 | 54822 HGNC:17994 | 1 | 20 | 0 | 0 | 1,313 | 2,329 |
| IL15RA interleukin 15 receptor subunit alpha | 3601 HGNC:5978 | 1 | 425 | 2 | 35 | 2,033 | 2,328 |
| SIRT5 sirtuin 5 | 23408 HGNC:14933 | 1 | 38 | 0 | 0 | 1,222 | 2,327 |
| ACO1 aconitase 1 | 48 HGNC:117 | 1 | 36 | 0 | 0 | 1,242 | 2,325 |
| NEFH neurofilament heavy chain | 4744 HGNC:7737 | 1 | 49 | 0 | 0 | 1,307 | 2,325 |
| SCN8A sodium voltage-gated channel alpha subunit 8 | 6334 HGNC:10596 | 1 | 46 | 84 | 1,303 | 1,300 | 2,325 |
| HDGFL2 HDGF like 2 | 84717 HGNC:14680 | 1 | 135 | 0 | 0 | 701 | 2,323 |
| IL1RAP interleukin 1 receptor accessory protein | 3556 HGNC:5995 | 1 | 177 | 3 | 39 | 1,589 | 2,323 |
Code
curl "https://conductscience.org/api/genes/v1?page=134"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=134
{
"data": {
"total": 193990,
"results": [
{
"id": "22925",
"title": "PLA2R1: phospholipase A2 receptor 1",
"summary": "NCBI Gene 22925. 1 protein, 67 patents, 0 drugs, 0 trials, 591 NIH grants and 2,349 papers.",
"record": "/library/genes/22925",
"gene_id": 22925,
"symbol": "PLA2R1",
"name": "phospholipase A2 receptor 1",
"hgnc_id": "HGNC:9042",
"counts": {
"proteins": 1,
"patents": 67,
"drugs": 0,
"trials": 0,
"grants": 591,
"papers": 2349
}
},
{
"id": "85363",
"title": "TRIM5: tripartite motif containing 5",
"summary": "NCBI Gene 85363. 1 protein, 35 patents, 0 drugs, 0 trials, 1,840 NIH grants and 2,349 papers.",
"record": "/library/genes/85363",
"gene_id": 85363,
"symbol": "TRIM5",
"name": "tripartite motif containing 5",
"hgnc_id": "HGNC:16276",
"counts": {
"proteins": 1,
"patents": 35,
"drugs": 0,
"trials": 0,
"grants": 1840,
"papers": 2349
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=135",
"request_id": "mpSpG0b3DiOHEgwS"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant